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Summary: The introduction of assays for the intact parathyrin (parathyroid hormone) has dramatically
improved the diagnosis and follow-up of patients with primary hyperparathyroidism. However, in some
patients with mild or intermittent hypercalcaemia, when plasma concentrations of intact parathyrin may be
within the normal reference concentrations, the diagnosis of primary hyperparathyroidism may still be
problematic. In these patients, the EDTA-infusion test is of potential value, as it also might be in patients
with equivocal operative findings.
Definition and Diagnosis
of Primary Hyperparathyroidism
Primary hyperparathyroidism is characterized by in-
creased secretion of parathyrin (parathyroid hor-
mone) in combination with increased parathyroid par-
enchymal cell mass. In primary hyperparathyroidism
the secretion of parathyrin is higher than that required
for the maintenance of nörmocalcaemia, which leads
to manifest hypercalcaemia. The biochemical diag-
nosis of primary hyperparathyroidism, therefore, con-
sists in demonstrating hypercalcaemia in combination
with a relative or absolute increase in plasma concen-
trations of parathyrin.
Hypocalcaemia Provocation Tests
The demonstration of increased plasma concentration
of parathyrin is vital for the differential diagnosis of
primary hyperparathyroidism from hypercalcaemia
due to other diseases. This used to be a clinical prob-
lem, since the radioimmunological assays used for the
determination of parathyrin also measured fragments
of the hormone, the concentration of which exceed
that of the intact hormone (1). Other tests were there-
fore introduced and initially held to be of value in the
diagnosis of primary hyperparathyroidism — e.g.,
determination of urinary excretion of calcium, hy-
droxyproline or cyclic AMP, measurement of the uri-
nary chloride to phosphate ratio or of the circulating
concentrations of vitamin D metabolites or osteocal-
cin. These tests have failed, however, to contribute
any useful diagnostic information (2). Similarly, ve-
nous catheterization for measurement of the local
concentration of parathyrin has not been found to be
of diagnostic value, although such a procedure might
be of use in the preoperative localization of the en-
larged parathyroid gland (3). To improve the diag-
nosis of primary hyperparathyroidism other tests
seemed to be required, and hypocalcaemia provoca-·
tion tests were developed. In these tests, hypocalcae-
mia is induced, which in turn stimulates parathyrin
secretion. The hypocalcaemia was induced by calci-
tonin or EDTA (ethylenediamine tetraacetate) (4 — 6).
The theoretical basis for the hypocalcaemia provo-
cation tests is the inverse S-shaped relationship be-
tween the extracellular concentration of calcium and
parathyrin secretion (fig. 1 (7)). The basis for this
relation is the activation by extracellular calcium of
a membrane-bound receptor in the parathyroid cells
(fig. 2). This leads to opening of receptor-operated
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 6























Fig. 1. The relation between the extracellular concentration of
ionized calcium and the secretion of parathyrin. The
inverse, S-shaped relation is mathematically described
by a 4-quantity relation involving the quantities A, B,
D and the "set point". For a detailed explanation see
the text.
membrane-bound calcium channels, which leads in
turn to uptake of extracellular calcium. Activation of
the calcium receptor also initiates phosphoinositide
hydrolysis, resulting in formation of inositol-1,4,5-
trisphosphate, with the subsequent liberation of cal-
cium from intracellular calcium storage sites. Both
these processes increase the cytoplasmic concentration
of calcium, which is followed by inhibition of the
parathyrin secretion. Conversely, during hypocalcae-
mia the intracellular calcium concentration is reduced,
which stimulates parathyrin secretion.
Figure 1 shows that the steepest part of the relation
between extracellular calcium and parathyrin secre-
tion is close to the calcium concentration that inhibits
the parathyrin secretion by 50°^o. This calcium value
is called the "set point", and it is close to the concen-
tration of plasma ionized calcium that is normally
seen (8). The curvilinear relation between calcium and
parathyrin has been characterized by four different
quantities, as shown in figure 1. Quantity A is the
maximal parathyrin secretion obtained during hypo-
calcaemia, whereas quantity D is the minimal secre-
tion seen after maximal hypercalcaemia. Quantity C
is the "set point" and quantity B is a quantity related
to the slope of the curve at the "set point". The
secretion of parathyrin (i. e., Y) is dependent on the
extracellular calcium (i.e., X) according to the relation
Υ = A^D/[1 + (X/C)B] + D (7).
Changes in the Calcium-Parathyrin-Relation in Pri-
mary Hyperparathyroidism
The normal relation between extracellular calcium
and parathyrin secretion is altered in patients with
primary hyperparathyroidism, since calcium does not
normally inhibit parathyrin secretion. There exists
evidence that this defective sensitivity to calcium is
due to a down-regulation of the calcium receptor in
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high intracellular calcium concentration to induce in-
hibition of parathyrin secretion, a higher extracellular
concentration of calcium is required in primary hy-
perparathyroidism than under normal conditions.
Consequently, a patient with primary hyperparathy-
roidism has a right-shifted relation between extracel-
lular calcium and parathyrin secretion when com-
pared to a healthy individual, i.e., primary hyperpara-
thyroidism is associated with an increased "set point"
(fig. 3).
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Fig. 3. The right-shifted inverse S-shape relationship between
extracellular calcium and the parathyrin secretion in
patients with primary hyperparathyroidism (right curve)
compared with healthy subjects (left curve).
By reducing the extracellular calcium concentration,
by means of calcitonin of EDTA, and by measuring
the plasma parathyrin concentrations, the highest
concentration of calcium that stimulates the para-
thyrin secretion can be measured: in primary hyper-
parathyroidism this occurs at calcium concentrations
exceeding the upper reference concentration for nor-
mality. In contrast, in patients with hypercalcaemia
due to other causes, parathyrin secretion is not stim-
ulated until the calcium concentration has dropped
to concentrations within the normal -range. The hy-
pocalcaemia provocation tests, therefore, are able to
distinguish hypercalcaemic patients with primary hy-
perparathyroidism from those with malignancy, for
example (4—6).
Intact Parathyrin
In the late 1980s new immunoradiometric and im-
munochemilunometric assays for the determination
of parathyrin were introduced. These assays measure
intact parathyrin without interfering with inactive
parathyrin fragments (10). With these assays an al-
most complete separation is established between hy-
percalcaemic patients with primary hyperparathyroid-
ism and those with malignancy (10). By the use of
these new assays for intact parathyrin, the need for
hypocalcaemia-provocation tests in the diagnosis of
primary hyperparathyroidism initially seemed to be
eliminated. However, it has been established that the
new assays for intact parathyrin can not completely
separate patients with primary hyperparathyroidism
from normal individuals (10). This has been explained
by the high sensitivity of the tests, since parathyrin
secretion under normal conditions is pulsatile with a
circadian variation (11). Therefore, the concentration
of intact parathyrin might occassionally be normal in
a patient with primary hyperparathyroidism. This
might present a particular diagnostic problem in pa-
tients with mild or intermittent hypercalcaemia, since
there is a correlation between the calcium concentra-
tion and the intact parathyrin concentration (12). In
such cases, a hypocalcaemia provocation test might
be useful.
EDTA-Infusion Test
We undertake the EDTA-infusion test followed an
overnight fast with the patient placed in a recumbent
position. An antecubital catheter is inserted on both
sides. From one catheter blood samples are taken
regularly, whereas the infusions are given through the
other catheter. Six g Na2EDTA are dissolved in 250
ml saline and infused intravenously with a constant
infusion rate of 24 mg/h · kg body weight, i. e., by 1.0
ml/h · kg. During the infusion, local discomfort or
pain might be felt in the arm, sometimes radiating to
the shoulder. This pain is reduced by infusing lidocain.
We dissolve 200 mg lidocain in 250 ml saline and
infuse up to 20 ml/hour. We have found that the local
discomfort is usually prevented by preinfusing lido-
cain at the rate of 10 ml/h our before starting the
EDTA infusion.
EDTA is infused for 70 minutes. Before, during, and
after the infusion, blood samples are taken every 10
minutes. One sample is taken anaerobically in pre-
heparinised tubes for the determination of ionized
calcium, whereas another sample is taken for the
analyses of intact parathyrin. Before the test, the
kidney function needs to be estimated, since in the
case of kidney damage, the infusion of EDTA might
be hazardous. We therefore routinely analyse the se-
rum concentration of creatinine in all cases before the
EDTA infusion test. No other precautions are re-
quired, however.
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Results of EDTA-Infusion-Tests
We have shown in a previous paper (13) that, when
using an EDTA-infusion test in the diagnosis of pri-
mary hyperparathyroidism, determination of intact
parathyrin is superior to that of the mid-molecule C-
terminal parathyrin. We showed that in 15 patients
with primary hyperparathyroidism the concentration
of intact parathyrin rose by 240% during the EDTA
infusion test, whereas the concentration of mid-mol-
ecule C-terminal parathyrin rose by only 65%
(P < 0.01). Furthermore, in four patients with pri-
mary hyperparathyroidism, the concentration of mid-
molecule C-terminal parathyrin did not rise at all
during the EDTA infusion, while the concentration
of intact parathyrin rose significantly in these patients.
Intact parathyrin should, therefore, be determined
when using EDTA-infusion tests.
Figure 4 shows the result of the EDTA-infusion test
in a healthy subject compared with that in a patient
with primary hyperparathyroidism. As is seen in the
upper panel of the figure, the concentration of ionized
calcium is reduced by approximately 0.15 mmol/1
during the 70 min EDTA-infusion test, and the middle
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Fig. 4. Serum concentration of ionized calcium (upper panel)
and plasma concentration of intact parathyrin (middle
panel) before, during and after the 70 min EDTA-
infusion test in a patient with primary hyperparathy-
roidism (· —·) and in a healthy subject (o—o). The
lower panel shows the values transformed into a cal-
cium-parathyrin-relation-curve.
intact parathyrin is increased in both individuals. In
the patient with primary hyperparathyroidism, the
plasma concentration of intact parathyrin already
starts to rise when the concentration of ionized cal-
cium approaches 1.35 mmol/1 (the upper reference
value is 1.29 mmol/1), whereas the corresponding cal-
cium value in the healthy subject is 1.21 mmol/1. This
difference illustrates the increased "set point" in pa-
tients with primary hyperparathyroidism and is di-
agnostic for the disease. The lower panel of the figure
shows the values in these individuals transformed to
a calcium^parathyrin^relation-curve. The right-shifted
relation in the patient with primary hyperparathy-
roidism compared with the healthy individual is
clearly illustrated.
The interpretation of the EDTA-infusion test is more
difficult in patients with mild hypercalcaemia with
only a slightly increased "set point". Figure 5 shows
such a patient. The figure shows the concentration of
intact parathyrin in relation to the concentration of
ionized calcium during and immediately after the
EDTA-infusion test. It can be seen that when the
plasma concentration of intact parathyrin starts to
rise the concentration of ionized calcium is within the
normal reference values. It is, however, known that
when the calcium concentration is changed very
slowly or not at all, as is the case in the sample taken
immediately after the end of the EDTA-infusion test,
the concentration of intact parathyrin shows its clos-
est correlation to the absolute calcium concentration
(14). Thus, the diagnostic efficiency is highest when
the concentration of intact parathyrin is interpreted
in the samples taken immediately after the end of the
infusion of EDTA: if intact parathyrin concentrations
then are raised and the calcium concentration is nor-
mal, the patient has primary hyperparathyroidism,
whereas if intact parathyrin is within normal concen-
trations, the patient does not have primary hyperpara-
thyroidism (12). The patient in figure 5, therefore, has
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Fig. 5. The relation between the plasma concentration of intact
parathyrin and the serum cqncentration of calcium dur-
ing (·-·) and immediately after (o—o) the EDTA-
infusion test in a patient with mild primary hyperpara-
thyroidism.
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primary hyperparathyroidism, since intact parathyrin
in the last sample is 7.4 pmol/1 (upper reference value
5.0 pmol/1), whereas the ionized calcium concentra-
tion is normal (1.22 mmol/1).
The Use of the EDTA-infusion Test in the Diagnosis
of Primary Hyperparathyroidism
To distinguish hypercalcaemic patients with primary
hyperparathyroidism from those with malignancy, de-
termination of the basal concentration of intact par-
athyrin is usually sufficient (10). The clinical problem
today is distinguishing patients with mild primary
hyperparathyroidism from normal individuals. These
patients have mild, or even only intermittent, hyper-
calcaemia, but the basal concentration of intact par-
athyrin is within the normal limits. They may or may
not be symptomatic. Recent studies have suggested
that this patient group is not small (15). The EDTA-
infusion test might be diagnostic in these patients.
Hence, even though the introduction of assays for
intact parathyrin has markedly improved the diag-
nostic accuracy for primary hyperparathyroidism,
there is still a need for hypocalcaemia provocation
tests in a subgroup of patients with primary hyper-
parathyroidism.
We recently examined the value of intact parathyrin
in 26 consecutive patients with hypercalcaemia and
suspected primary hyperparathyroidism, of whom all
except one at operation also were demonstrated to
have the disease (12). We used a commercially avail-
able immunoradiometric assay for intact parathyrin
with an inter-assay variation of < 10% and an intra-
assay variation of < 6%, when expressed as coeffi-
cients of variation. We found that in six of the 25
cases shown to have primary hyperparathyroidism,
the intact parathyrin concentration was within the
normal range. This high incidence of patients with
normal concentrations of intact parathyrin is in agree-
ment with a recent study (10), but in contrast with
earlier reports where the incidence of primary hyper-
parathyroidism with normal intact parathyrin con-
centrations was lower. A likely explanation for this
differences would be different selections of patients in
different studies. In five of our cases with normal
values of intact parathyrin we performed the EDTA-
infusion test. The test was positive, i.e., diagnostic
for primary hyperparathyroidism, in all five patients,
who at operation were shown to have the disease.
Thus, our experience is that the EDTA-infusion test
is of diagnostic value in this subset of patients with
'suspected primary hyperparathyroidism.
The EDTA-infusion Test in the Follow-up of Patients
with Primary Hyperparathyroidism
Both molecular biological (16) and functional (17)
studies have presented evidence that parathyroid ad-
enomas are of monoclonal origin and that, therefore,
the non-adenomatous glands are normal. This indi-
cates that the "set point" should not be raised post-
operatively in patients with adenomas, as we have
demonstrated as well (17). Hence, in patients operated
on for primary hyperparathyroidism but who have
equivocal operative findings, a postoperative EDTA-
infusion test could be of clinical value. If the post-
operative uset point" is not raised, it can be concluded
that the operation has been a success.
Conclusion
Our review has shown that, despite the introduction
of sensitive assays for intact parathyrin, there is a
need for an EDTA-infusion test in a subset of patients
with suspected primary hyperparathyroidism, mainly
in those with mild or intermittent hypercalcaemia and
a normal basal concentration of intact parathyrin.
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